The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
1
Crouch, Bronson
Business Executive born in January 1973Individual (1 offspring)Officer
2020-03-25 ~ nowOF - Director → CIF 0
Ceased
8
- 1
Matcham, George, Dr
Business Executive born in March 1952IndividualOfficer 2020-03-25 ~ 2020-05-31OF - Director → CIF 0Matcham, George, Dr
Scientist born in March 1952Individual 2020-03-13 ~ 2020-09-03OF - Director → CIF 0 - 2
Mackenzie, Neill Moray, Dr
Doctor born in December 1953Individual (4 offsprings)Officer 2014-11-01 ~ 2020-03-25OF - Director → CIF 0 - 3
Hawkins, Robert Edward, Dr
Dr born in December 1955Individual (6 offsprings)Officer 2008-09-29 ~ 2020-09-03OF - Director → CIF 0Mr Robert Hawkins
Born in December 1955Individual (6 offsprings)Person with significant control 2016-04-06 ~ 2020-03-02PE - Ownership of shares – More than 25% but not more than 50% → CIF 0 - 4
Hawkins Medical Ltd
IndividualOfficer 2008-09-29 ~ 2010-04-28OF - Secretary → CIF 0 - 5
Crouch, Bronson
Businessman born in December 1973Individual (1 offspring)Officer 2020-03-25 ~ 2020-03-25OF - Director → CIF 0 - 6
Price, Nicola Kaye, Dr
Director born in August 1979Individual (1 offspring)Officer 2017-03-30 ~ 2020-03-02OF - Director → CIF 0Price, Nicola Kaye, Dr
Individual (1 offspring)Officer 2010-04-28 ~ 2020-03-02OF - Secretary → CIF 0 - 7
Roberts, Margo, Dr
Scientist born in May 1955IndividualOfficer 2020-03-24 ~ 2020-05-25OF - Director → CIF 0 - 8
Guest, Ryan
Director born in October 1972Individual (1 offspring)Officer 2016-09-23 ~ 2020-03-02OF - Director → CIF 0Mr Ryan Guest
Born in October 1972Individual (1 offspring)Person with significant control 2016-04-06 ~ 2020-03-02PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
Company in focus
INSTIL BIO (UK) LIMITED
Previous names
CELLULAR THERAPEUTICS LTD - 2018-03-29
IMMETACYTE LIMITED - 2020-07-02
Standard Industrial Classification
86900 - Other Human Health Activities
72110 - Research And Experimental Development On Biotechnology
Brief company account
Property, Plant & Equipment
0 GBP2024-12-31
926,987 GBP2023-12-31
Debtors
1,861,724 GBP2024-12-31
2,300,109 GBP2023-12-31
Cash at bank and in hand
38,067 GBP2024-12-31
431,150 GBP2023-12-31
Current Assets
1,899,791 GBP2024-12-31
2,731,259 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-6,995,710 GBP2024-12-31
-11,247,907 GBP2023-12-31
Net Current Assets/Liabilities
-5,095,919 GBP2024-12-31
-8,516,648 GBP2023-12-31
Total Assets Less Current Liabilities
-5,095,919 GBP2024-12-31
-7,589,661 GBP2023-12-31
Creditors
Non-current, Amounts falling due after one year
-60,000 GBP2024-12-31
0 GBP2023-12-31
Net Assets/Liabilities
-5,155,919 GBP2024-12-31
-7,589,661 GBP2023-12-31
Equity
Called up share capital
31,652 GBP2024-12-31
31,652 GBP2023-12-31
31,652 GBP2022-12-31
Share premium
126,600 GBP2024-12-31
126,600 GBP2023-12-31
126,600 GBP2022-12-31
Other miscellaneous reserve
40,359,518 GBP2024-12-31
32,392,213 GBP2023-12-31
Retained earnings (accumulated losses)
-45,673,689 GBP2024-12-31
-40,140,126 GBP2023-12-31
-25,233,287 GBP2022-12-31
Equity
-5,155,919 GBP2024-12-31
-7,589,661 GBP2023-12-31
Profit/Loss
Retained earnings (accumulated losses)
-5,533,563 GBP2024-01-01 ~ 2024-12-31
-14,906,839 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-5,533,563 GBP2024-01-01 ~ 2024-12-31
-14,906,839 GBP2023-01-01 ~ 2023-12-31
Average Number of Employees
292024-01-01 ~ 2024-12-31
682023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Land and buildings
0 GBP2024-12-31
1,288,867 GBP2023-12-31
Other
0 GBP2024-12-31
8,903,089 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
0 GBP2024-12-31
10,191,956 GBP2023-12-31
Property, Plant & Equipment - Other Disposals
Land and buildings
-1,288,867 GBP2024-01-01 ~ 2024-12-31
Other
-8,903,089 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals
-10,191,956 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings
0 GBP2024-12-31
1,273,727 GBP2023-12-31
Other
0 GBP2024-12-31
7,991,242 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
0 GBP2024-12-31
9,264,969 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Land and buildings
15,140 GBP2024-01-01 ~ 2024-12-31
Other
597,167 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
612,307 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Land and buildings
-1,288,867 GBP2024-01-01 ~ 2024-12-31
Other
-8,588,409 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-9,877,276 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Land and buildings
0 GBP2024-12-31
15,140 GBP2023-12-31
Other
0 GBP2024-12-31
911,847 GBP2023-12-31
Amount of corporation tax that is recoverable
Current
1,282,755 GBP2024-12-31
1,073,147 GBP2023-12-31
Other Debtors
Amounts falling due within one year
578,969 GBP2024-12-31
1,226,962 GBP2023-12-31
Debtors
Current, Amounts falling due within one year
1,861,724 GBP2024-12-31
2,300,109 GBP2023-12-31
Trade Creditors/Trade Payables
Current
54,522 GBP2024-12-31
967,902 GBP2023-12-31
Amounts owed to group undertakings
Current
6,169,923 GBP2024-12-31
8,633,037 GBP2023-12-31
Other Taxation & Social Security Payable
Current
361,522 GBP2024-12-31
195,040 GBP2023-12-31
Other Creditors
Current
409,743 GBP2024-12-31
1,451,928 GBP2023-12-31
Creditors
Current
6,995,710 GBP2024-12-31
11,247,907 GBP2023-12-31
Other Creditors
Non-current
60,000 GBP2024-12-31
0 GBP2023-12-31
Par Value of Share
Class 1 ordinary share
1 GBP2024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
3,165,200 shares2024-12-31
3,165,200 shares2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
251,581 GBP2024-12-31
702,157 GBP2023-12-31
Related profiles found in government register
INSTIL BIO (UK) LIMITED
InfoCELLULAR THERAPEUTICS LTD - 2018-03-29IMMETACYTE LIMITED - 2018-03-29Registered number 06709883
Alderley Park Block 19, Congleton Road, Macclesfield SK10 4TFPrivate Limited Company incorporated on 2008-09-29 (17 years 1 month). The company status is Active.The last date of confirmation statement was made at 2024-09-28CIF 0IMMETACYTE LIMITED
SRegistered number 0670988348, Grafton Street, Manchester, United Kingdom, M13 9XXPrivate Limited Company in Companies House, United KingdomCIF 1
Offspring entities and appointments
Active
0
- Not found in our database.
Ceased
1
- IMMETACYTE LIMITED - 2018-03-29Block 19 Alderley Park, Block 19, Nether Alderley, Macclesfield, United KingdomDissolved Corporate (2 parents)Equity (Company account)0.04 GBP2022-08-31Person with significant control 2018-02-26 ~ 2019-11-19CIF 1 - Right to appoint or remove directors → OECIF 1 - Ownership of voting rights - 75% or more → OECIF 1 - Ownership of shares – 75% or more → OE
The content of this website is protected by AgonGuard.
© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 26 August 2025 and
licensed under the Open Government Licence v3.0.